| 发明名称 |
USE OF AT LEAST ONE CYTOSOLIC PHOSPHOLIPASE A2 INHIBITOR AS A MEDICINE FOR SYMPTOMATIC TREATMENT OF MUCOVISCIDOSIS |
| 摘要 |
The purpose of this invention is the use of at least one cytosolic phospholipase A2 (cPLA2) inhibitor in the preparation of a medicine intended for preventive and/or remedial symptomatic treatment of mucoviscidosis, and particularly the increased secretion of mucus in mucoviscidosis. |
| 申请公布号 |
WO2007118996(A3) |
申请公布日期 |
2008.04.10 |
| 申请号 |
WO2007FR00582 |
申请日期 |
2007.04.05 |
| 申请人 |
INSTITUT PASTEUR;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);DIF, FARIEL;TOUQUI, LHOUSSEINE |
发明人 |
DIF, FARIEL;TOUQUI, LHOUSSEINE |
| 分类号 |
A61K31/00;A61K31/12;A61K31/121;A61K31/40;A61K31/404;A61K31/43;A61K31/661;A61K45/06;A61P11/00;A61P11/06 |
主分类号 |
A61K31/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
